Advertisement

Clinical Pharmacokinetics

, Volume 29, Issue 5, pp 287–291 | Cite as

The Target Concentration Approach to Clinical Drug Development

  • Nicholas H. G. Holford
Leading Article

Keywords

Adis International Limited Theophylline Drug Development Target Concentration Target Effect 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Sheiner LB. The intellectual health of clinical drug evaluation. Clin Pharmacol Ther 1991; 50: 4–9PubMedCrossRefGoogle Scholar
  2. 2.
    Peck CC. Clinical new drug development: how golden are the eggs? Boerhaave Professorship Inaugural Lecture, Leiden University, The Netherlands, 25 Mar 1994Google Scholar
  3. 3.
    Breimer DD. The relevance of the application of PK/PD modelling concepts. Keynote lecture, 2nd International Symposium on Measurement and Kinetics of In Vivo Drug Effects: 1994 Apr 14–16; Leiden, The NetherlandsGoogle Scholar
  4. 4.
    Peck CC, Barr WH, Benet LZ, et al. Opportunities for the integration of pharmacokinetics, pharmacodynamics and toxicokinetics in rational drug development. Clin Pharmacol Ther 1992; 51: 465–73PubMedCrossRefGoogle Scholar
  5. 5.
    Sheiner LB, Tozer TN. Clinical pharmacokinetics: the use of plasma concentrations of drugs. In: Melmon KL, Morelli HF, editors. Clinical pharmacology: basic principles of therapeutics. New York: Macmillan; 1978: Chap. 3, 71–109Google Scholar
  6. 6.
    Collins JM, Grieshaber CK, Chabner BA. Pharmacologically guided phase I clinical trials based upon preclinical drug development. J Natl Cancer Inst 1990; 82: 1321–6PubMedCrossRefGoogle Scholar
  7. 7.
    Holford NHG, Williams PEO, Muirhead GJ, et al. Population pharmacodynamics of romazarit. Br J Clin Pharmacol 1995; 39: 313–20PubMedCrossRefGoogle Scholar
  8. 8.
    Vozeh S, Kewitz G, Perruchoud A, et al. Theophylline serum concentrations and therapeutic effect in severe acute bronchial obstruction: the optimal use of intravenously administered theophylline. Am Rev Respir Dis 1982; 125: 181–4PubMedGoogle Scholar
  9. 9.
    Holford NHG, Black P, Briant R, et al. Theophylline target concentration in severe airways obstruction — 10 or 20 mg/L? A randomised concentration-controlled trial. Clin Pharmacokinet 1993; 25: 495–505PubMedCrossRefGoogle Scholar
  10. 10.
    Holford NHG, Hashimoto Y, Sheiner LB. Time and theophylline concentration help explain the recovery of peak flow following acute airways obstruction. Population analysis of a randomised concentration controlled trial. Clin Pharmacokinet 1993; 25: 506–15PubMedCrossRefGoogle Scholar
  11. 11.
    Sanathan L, Peck CC. The randomized concentration-controlled trial: an evaluation of its sample size efficiency. Controlled Clin Trials 1991; 12: 780–94CrossRefGoogle Scholar
  12. 12.
    Levy G. Concentration-controlled versus concentration-defined trials. Clin Pharmacol Ther 1993; 53: 385PubMedCrossRefGoogle Scholar
  13. 13.
    Levy G. Rebuttal: Concentration-controlled versus concentrationdefined trials. Clin Pharmacol Ther 1993; 53: 387CrossRefGoogle Scholar
  14. 14.
    Peck CC. Reply: Concentration-controlled versus concentrationdefined trials. Clin Pharmacol Ther 1993; 53: 385–7CrossRefGoogle Scholar
  15. 15.
    Endrenyi L, Zha J. Comparative efficiencies of randomized concentration- and dose-controlled trials. Clin Pharmacol Ther 1994; 56: 331–8PubMedCrossRefGoogle Scholar
  16. 16.
    Levy G, Ebling WF, Forrest A. Concentration- or effect-controlled trials with sparse data. Clin Pharmacol Ther 1994; 56: 1–8PubMedCrossRefGoogle Scholar
  17. 17.
    Holford NHG, Peck CC. Population pharmacodynamics and drug development. In: Van Boxtel C, Holford NHG, Danhof M, editors. The in vivo study of drug action. Amsterdam: Elsevier; 1992: 401–13Google Scholar

Copyright information

© Adis International Limited 1995

Authors and Affiliations

  1. 1.Department of Pharmacology and Clinical PharmacologyUniversity of AucklandAucklandNew Zealand

Personalised recommendations